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Summary.-The transfer of tumour-specific cytotoxicity against a murine fibrosar-
coma has been demonstrated in vitro using xenogeneic RNA extracted from tumour-
cell-immune animals. Poly(A)-tailed messenger RNA from immunogenic RNA was
isolated by passage through an oligo(dT)-cellulose column, and evaluated to deter-
mine whether the same tumour-specific cytotoxicity could be transferred. Aliquots
of normal C3H mouse lymphocytes were treated with poly(A)-containing immune
RNA, whole-cell immune RNA lacking poly(A) and total cellular immune RNA.
Treated cells were tested in vitro using an adaptation of the Takasugi and Klein
microcytotoxicity assay. Percent cytotoxicity was calculated using cells treated with
fractions of normal RNA as control. An increase in tumour cytotoxicity was found
with poly(A)-containing immune RNA. The optimum dose of poly(A)-tailed immune
RNA was estimated as 6*5 ,ug of RNA per 4 x 106 lymphocytes. Populations of lympho-
cytes were separated using glass and nylon wool. T- and B-enriched populations
were treated with various RNA components. The adherent cell population showed no
significant cytotoxicity, whilst treatment of the nonadherent population with poly(A)-
tailed immune RNA produced high levels of cytotoxicity.
RIBONUCLEIC ACID (RNA) extracted
from sensitized lymphoid cells has been
shown to transfer immunological respon-
siveness. This immunogenic RNA (IRNA)
free of detectable antigen has been shown
to induce humoral antibody production
(Bell and Dray, 1973; Cohen and Parks,
1964; Mitsuhashi et at., 1968; Pinchuck et
al., 1968) and to induce cellular immunity
(Likhite and Sehon, 1972; Paque and
Dray, 1972; Thor and Dray, 1973). The
mediation of anti-tumour cytotoxicity in
vitro has been demonstrated using both
syngeneic (Kern et al., 1974; Schlageret al.,
1975) and xenogeneic IRNA (Alexander
et al., 1967; Brower et al., 1975; Dodd et al.,
1973; Kern and Pilch, 1974; Pilch et al.,
1974). In most cases the technique used to
assess cell-mediated transfer with IRNA
was in the form ofa microcytotoxicity test
in which tumour target-cell destruction
was noted. Less used assays were designed
to detect migration-inhibition factor
(Schlager et al., 1975; Thor and Dray,
1973) and lymphoblastogenesis (Deckers
et al., 1975; Dodd et al., 1973). The in vivo
models for mediation of specific tumour
cytotoxicity produced results demonstrat-
ing temporary tumour regression (Alex-
ander et al., 1967; Schlager et al., 1975),
decreased rate (Londner et al., 1968), or
inhibition of tumour growth (Ramming
and Pilch, 1970; Skinner et at., 1976) and
protection against tumours with prolonged
survival (Kennedy et al., 1969; Rigby,
1969).
The intracellular location of IRNA from
sensitized lymphocytes was found to be
in the nucleus-free cytoplasmic fractions
(deKernion et al., 1974). The immunologic-
ally active components of total cellular
IRNA were found to have sedimentation
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values of 10-1 68 (Billello et al., 1976; Dodd
et al., 1973; Kern et al., 1976) and to con-
tain sequences ofpolyadenylic acid (Paque
and Nealon, 1977). Wlhile it is apparent
that IRNA is capable of transferring a
variety of immune responses, the active
component of IRNA seems to be confined
to a narrow range of sedimentation co-
efficients. Since IRNA has been shown to
function in both the humoral and cellular
responses, perhaps they are operating, at
least in the initial stages, by similar me-
chanisms. These studies were undertaken
to define further the role ofthis fraction of
IRNA in initiating an immune response.
Poly(A)-containing messenger RNA
(mRNA) was isolated by the use of oligo-
(dT)-cellulose chromatography from total
cellular syngeneic IRNA. Most eucaryotic
mRNAs contain a poly(A) segment at
their 3'-hydroxyl end (Adesnik et al., 1972;
Lee et al., 1971) and thus bind to oligo(dT)-
cellulose at the appropriate ionic strength
(Mach et al., 1973). Increased levelsofcyto-
toxicity were found in the poly(A)-con-
taining fraction of IRNA. The transfer of
tumour cytotoxicity with poly(A)-contain-
ing IRNA (poly(A)+IRNA) would support
the theory that IRNA operates as infor-
mational RNA.
It has not been clear whether the cyto-
toxicity observed in similar studies has
been due to direct lymphocyte-tumour cell
interaction (e.g. T-cell killing). This study
investigates the ability of this poly(A)+
IRNA to transfer specific cytotoxicity to
nylon-wool-purified populations of lym-
phocytes. The non-adherent cells were the
active recipients of the poly(A)+IRNA
component, while from these studies the
adherent cells appeared to play no role in
the transfer of specific cytotoxicity.
MIATERIALS AND METHODS
Animials. The animals used were inbred
C3H/HeJ mice 6-12 w%Aeeks old (Jackson
Laboratories, Bar Harbor, Maine).
Cell lines.-The tumour system used was a
polyoma-virus-induced fibrosarcoma of C3H
mouse origin termed 4198. A variant, 4198V,
cloned from 4198, lhas been shown to contain
about 9 times more tumour-specific antigen
than 4198 on its cell surface. The more tu-
morigenic 4198 was used to produce tumours,
whereas 4198V was used to immunize mice
(Ting et al., 1972). The 4198V cell also served
as a target cell in assays detecting tumour-
specific immune activity. The LM cell, cloned
from L cells (Kuchler and Merchant, 1956)
was used as a control cell. LM is a non-
tumorigenic cell ofC3H mouse origin. Another
tumour cell line, S91, was used as a control of
specificity. S91 is a malignant melanoma
transplant that arose spontaneously in a DBA
female mouse and has been shown to be
tumorigenic in C3H/HeJ mice (Cloudman,
1941).
Cell culturing.-All cell lines were main-
tained in vitro at 37°C and 50% CO2 as mono-
layer cultures in RPMI-1640 plus 10% heat-
inactivated foetal calf serum (FCS) (Grand
Island, N.Y.).
Immunization of mice.-Mice (C3H/HeJ)
were given 3 i.p. injections of 4 x 106 4198V
tumour cells every 5-6 days. Five days after
the last injection, mice were challenged with
5 X 105 of 4198 tumour cells. Non-immune
mice will produce palpable tumours in 10-14
days after i.m. injection of5 x 105 4198V cells.
Mice resisting tumour challenge were con-
sidered immune, and their spleens were re-
moved and frozen in dry-ice/acetone. The
control cell lines LM and S91 were used to
immunize C3H mice in the same manner as
the 4198V, with the exception of the non-
tumorigenic LM cell, for which mice were
given 5 x 106 cells per injection.
RAVA extraction.-RNA was extracted from
frozen normal and immune C3H/HeJ mouse
spleens according to the methods described
in a previous paper (Dodd et al., 1973).
Isolation of poly(A)-tailed mRNA.-Total
cellular RNA at a concentration of 20-50
A260 u/ml (A standard 1 mg/ml solution ab-
sorbs 24 units at 260 nm) in O.i1M Tris-HCl
(pH 7 4) and 0-5M NaCl was applied to an
oligo(dT)-cellulose column (Collaborated Re-
search, Waltham, Mass.) with a bed volume of
2 ml (0 4 g powder). The column was pre-
viously equilibrated with the same buffer. The
column was washed twice with twice the bed
volume (4 ml) to remove unbound material.
The RNA that failed to bind to the column
was passed through, collected and termed
poly(A)-lacking RNA (poly(A)-RNA). Poly-
(A)+RNA was eluted with 2 ml of diethyl-
pyrocarbonate (Sigma, St. Louis, Mo.) treated
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triple-distilled H20. Both fiactions were pre-
cipitated by adjusting the salt concentration
to 0dIM with lOX TNE (O.1M Tris, IM NaCl,
001M EDTA, pH 8 3) and by the addition of
2 volumes ofabsolute ethanol at -20°C over-
night. The preparations were centrifuged for
30 min at 12,000 g in a Sorvall Model RC2-B
centrifuge at -20°C. The resulting RNA pel-
lets were dissolved in Ca+2- and Mg+2-free
phosphate-buffered saline and frozen at
-70°C. The oligo(dT)-cellulose wasregenerat-
ed by washing with 0-M NaOH and re-
equilibrated with 0-O1M Tris-HCl (pH 7 4)
containing 0-5M NaCl. Chromatography on
oligo(dT)-cellulose was performed at room
temperature.
Sucrose density-gradient evaluation. Suc-
rose gradients of 5-20% sucrose (Sigma, St.
Louis, Mo.) were formed by an ISCO Model
180 gradient former. Fifty to 100 ,tg of IRNA
were layered on the surface of the gradient,
followed by centrifugation in a Beckman
Model L-2 ultracentrifuge at 193,000 g in an
SW 41 swinging bucket rotor for 5 h at 4°C.
Using an ISCO Model 180 density-gradient
fractionator, the sucrose gradient was frac-
tionated and absorbance (A) read at 254 nm
through the flow cell of an ISCO Model 222
spectrophotometer.
The preceding preparative methods were
performed on RNA from normal C3H/HeJ
mice (NRNA) and from immunized C3H/HeJ
mice.
RNA treatment of lymphocytes. Lympho-
cytes were obtained from the spleens of nor-
mal C3H/HeJ mice. The spleens were teased
and cells separated on a Hypaque-Ficoll gra-
dient (Boyum, 1968). The medium used was
RPMI 1640 containing 10% heat-inactivated
FCS, 20 jug gentamicin/ml (Schering, Kenil-
w%rorth, N.J.) buffered with HEPES (N-2-
hydroxyethylpiperazine-N-2-ethanesulphonic
acid, Grand Island Biologicals, Grand Island,
N.Y.) at pH 7-4. The lymphocytes were ad-
justed to a concentration of 2 x 106/ml and
were consistently 97-100% viable as deter-
mined bytrypan-blueexclusion. Lymphocytes
at a concentration of4 x 106/2 ml w,,ere treated
in plastic test tubes (Falcon Plastics, Cherry
Hill, N.J.) with 50 ,ug of DEAE-dextran and
a determined amount of RNA (50 jug, 100 ,ug,
etc.). The lymphocytes were incubated with
the RNA and DEAE-dextran for 30 min at
37°C and 500 CO2. After incubation the cells
were washed twice with medium described
above and adjusted to a cell concentration of
106/ml for use in the microcytotoxicity assay.
Microcytotoxicity assay.-The assay is an
adaptation of the Takasugi microcytotoxicity
assay (Takasugi and Klein, 1970). A single-
cell suspension of 4198V tumour cells, at a
concentration of 104/cells per ml, was seeded
into wells of 3034 Falcon microcytotoxicity
plates (Falcon Plastics, Cherry Hill, N.J.) in
0-01 ml aliquots (100 cells/well). The tumour
cells wAere allo'wed to attach for 12 h at 37°C
in 50 CO2. The wells were washed once with
fresh medium and treated lymphocyte sus-
pensions of 106/ml in 0.01 ml aliquots were
added to each wNell. The plates were incubated
40 h, at -which time the target cells were
washed with serum-free medium, fixed with
acetone/alcohol and stained with crystal
violet. The cells in the well of eaeh test rowr
wrere counted and averaged. The percent
cytotoxicity was calculated by using the
following formula:
mean of mean of
O/C-control wells test wvells x00
mean of control wx-ells
Separation ofT and B lymiphocytes on nylon-
antd glass-wool column,ns. Populations of lym-
phocytes were separated by glass and nylon
wool as previously described (Gravely and
Kreier, 1976). The numbers of 0+ cells Nere
determined by incubation of lymphocytes,
anti-0 serum, and complement (Filippi et al.,
1976). The percent 0+ cells was calculated
using lymphocytes treated with normal rabbit
serum as control. B cells will form rosettes
with sensitized complement-coated sheep ery-
throcytes termed EAC (Bianco et al., 1970).
The percent rosettes was calculated on the
basis of counting 100 cells after incubation of
equal volumes of 106/ml lymphocytes Awith
100 EAC.
RESULTS
RN'A fractionation and sucrose-yradient
profiles
The separation of poly(A)-containing
mRNA from total cellular RNA was
achieved by the use of oligo(dT)-cellulose.
The poly(A)+RNA fraction that elutes
with low ionic strength comprised 4-6%
ofthe total material applied to the column.
This was confirmed by OD readings each
time the column was used.C. J. GREENUP ET AL.
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FiG. 1.- Sucrose-gradient profiles of total cellular RNA (A), poly(A)- IRNA (B) andpoly(A)+ IRNA
(C). The RNA (100 Ig) was analysed on linear 5-20% sucrose (w/v) gradients in O-O1M Tris (pH
7-0), 0-05M NaCl and 0OO1M EDTA.
Analyses of whole-cell RNA and of the
RNA fractions on sucrose gradients are
shown in Fig. 1. The profile obtained with
whole-cell RNA (A) had 3 peaks: the low-
mol-wt (4-6S) RNA which contains trans-
fer RNA, the second peak at about 12-
20S which comprises mRNA and smaller
ribosomal RNA, and the larger-mol-wt
(20-35S) RNA which accounts for larger
ribosomal RNA. The profile obtained with
poly(A)-RNA (B) closely resembles that
found with total cellular RNA. Since
poly(A)+RNA makes up such a small
amount in comparison to total cell RNA
(4-6%), no significant difference should be
seen in sucrose-gradient profiles. The sedi-
mentation profile ofpoly(A)+RNA (C) ap-
peared as one broad peak ranging from
9 to 20S. The broadness of the peak sug-
gests that somecontaminationwithhigher-
mol-wt ribosomal RNA could be present
in the preparation. The profiles obtained
with these 3 RNA preparations agree with
similar reports using oligo(dt)-cellulose for
isolation of poly(A)-tailed mRNA (Green
et al., 1976). Unless the sucrose-gradient
profiles resembled those shown here, RNA
was not used for experimentation.
Target cellst
per well of
test
cells±s.e.
304±2
35:3
50±4
59±3
47±2
21±2
57±3
61±3
30±2
24±2
48±2
20±2
48±2
29±3
50±2
Target cellst
per well of
control
cells±s.e.
52±3
65±2
52±2
61±2
53± 3
21±2
59±2
65±3
54±3
50±2
54±3
19±2
79±3
42±3
55±3
Cytotoxicity**
42
46**
4
3
11
0
3
6
44**
52***
11
-5
39
31**
9
* NL, normal lymphocytes; IL, lymphocytes from the spleens of mice immune to cell line given in paren-
theses.
t RNA extracted from the spleens of mice immune to specific cell lines.
$ Mean of 18 replicate wells.
** Calculated as described in the text, using lymphocytes treated with normal RNA as control.
*** P<0.001.
TABLE I.-Specificity in the transfer ofcytotoxicity
Effector
cell
NL
IL(4198v)
NL
IL(4198V)
NL
IL(4198V)
NL
IL(LM)
NL
IL(LM)
NL
IL(ssl)
NL
IL(sgj)
NL
IRNAt
IRNA(4198V)
IRNA(49ssv)
IRNA(419 8V)
IRNA(LM)
IRNA(LM)
IRNA(ssl)
IRNA(ssl)
Target
cell
4198V
4198V
LM
LM
S91
S91
4198V
4198V
LM
LM
4198V
4198V
S91
S91
4198V
A
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Cytotoxicity
The microcytotoxicity assay was per-
formed using normal lymphocytes treated
with 100 )g of total cellular IRNA from 3
different sources. The RNA was extracted
from groups of mice immunized separately
to the 4198V, LM, and S91 cell lines. As
shown in Table I, lymphocytes treated
with IRNA extracted from the spleens of
41 98V-immune animals transferred 42%
tumour-specific cytotoxicity against the
4198V target cell, and 4%0 and H l% cyto-
toxicity against the LM and S91 target
cells respectively. Likewise, lymphocytes
treated with IRNA extracted from LM-
immune animals transferred 44%0 cyto-
toxicity against the LM cell and 3%0
against 4198V target cells. Similar results
were obtained using IRNA extracted from
891-immune animals. Cytotoxicity was
calculated using normal-RNA-treated
lymphocytes as control. The viability of
cells treated and untreated with RNA re-
>_
._
x 0
0 C-,.
mained constant throughout the assay.
These results agree with previous work
done in our laboratory (Dodd et al., 1973)
and others (Kern et al., 1976; Singh et al.,
1977).
Poly(A)-tailed mRNA was isolated from
total cellular IRNA using oligo(dt)-cellu-
lose chromatography, and normal lym-
phocytes were treated with doses of
poly(A)+IRNA ranging from ] 65 Mg to
32 5 Mug. As shown in Fig. 2, poly(A)+IRNA
transferred optimum activity (50%0) when
normal lymphocytes were treated with 6 5
Mg. Normal lymphocytes were also treated
with various doses of poly(A)-IRNA and
lower levels of cytotoxicity were trans-
ferred against the 4198VT target cell. This
background level of cytotoxicity obtained
with poly(A)-IRNA could be attributed
to small amounts of poly(A)+IRNA left in
the poly(A)-IRNA fraction. It has been
shown after passage through oligo(dT)-
cellulose, that poly(A)-RNA contains
mRNA lacking a poly(A) tail as well as
trace amounts of poly(A)+RNA (Green et
0
0
C-,
0ll
_
1.6 6.5 13.0 19.5 26 32.5 igg Poly(A)t
FIG. 2. The (lose response cutrve for the
transfer of cytotoxicity to normal lympho-
cytes by syngeneic poly(A)+ IRNA (0*)
andl poly(A)- IRNA (0). The control cells
were inormal lymphocytes treate(d with
variotus closes of poly (A)+ NRNA an(l poly
(A)- NRNA. Cytotoxicity calculated as
in Table I. Bars represents s.e. (Trivers et
al., 1976). The effector: target-cell ratio was
200:1.
-lo L
Fic. 3. The effect of varying the lymphocyte:
target-cell ratio in the transfei of cytotoxi-
city by 93-5 ,ug of poly (A)- IRNA (0) an(I
6-5 ,ug of poly (A)+ IRNA (@*). The control
cells were normal lymphocytes treated with
poly(A)- NRNA an(d poly(A)+ NRNA.
(ytoxicity calculated as in Table T. Bar-s
represent s.e.
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al., 1976). Normal lymphocytes treated
with various doses of poly(A)+NRNA and
poly(A)-NRNA were used as control.
The effect ofvarying the effector: target-
cell ratio from 1: 1 to 400: 1 is seen in Fig.
3. The optimum dose of poly(A)+IRNA
and poly(A)-IRNA was used as determ-
ined previously. Maximum activity was
observed using a 200: 1 effector: target-cell
ratio. Increasing the number of lympho-
cytes beyond this ratio did not increase
tumour-specific cytotoxicity.
Evaluation of glass- and nylon-wool
columns
Splenic lymphocytes were separated on
a Hypaque-Ficoll gradient and passed
through glass wool to remove macrophages
and then through nylon wool to separate
and enrich for B- and T-cell populations.
For unknown reasons, B lymphocytesstick
preferentially to nylon wool (Eisen et al.,
1 cI'729 Paqom- of hilman nerinheral-ohond
Fi(c. 4
lymphocytes through long nylon-wool
columns at 370C was shown to result in a
2-3-fold depletion of complement-receptor
lymphocytes (CRL) (Epstein et al., 1971).
As shown in Fig. 4, glass- and nylon-wool
columns were found to be effective for en-
riching for CRLs and 0+ lymphocytes. An
average of 550 ofthe total cell population
was recovered after passage through glass
wool, and 700% of the glass-wool yield was
recovered after passage through nylon
wool.
The population eluted from nylon wool
was 500o CRLs and 5% 0+ cells. The non-
adherent population was 86% 6+ cells and
300 CRLs. Even though some cells could
not be identified either by a complement
receptor or by the 0 antigen, the nylon-
wool technique did enrich for the two
populations. These percentages agree with
those reported previously (Gravely and
Kreier, 1976).
c,I
L clF- `'I' Cytotoxicity with adherent and non-adherent
populations of cells
Treatments with the various RNA com-
ponents were performed using nylon-wool
purified adherent and non-adherent popu-
lations of cells in place of unseparated
lymphocytes. These were substituted and
used in the microcytotoxicity assav. As
shown in Table II, no significant levels of
cytotoxicity were found, using adherent
cells, with any of the IRNA components.
In looking at the non-adherent cell popu-
lation, high levels of cytotoxicity (5900)
were found with poly(A)+IRNA. Likewise,
410% cytotoxicity was obtained with treat-
ment with total cellular IRNA and lower
lPlv. of 40/O with nIvA IA-TRMA Th1-o, urlginiul ATTer ryion 'ylon -l-r 'v--L- vL 0 /o W tJ"U1u.y J \) 1- w15!. JllI;ns
glass wool wool values agreed with those found in treating wool efflIuent elutedaged toefudi
an unseparated population withthesesame
.-Evaluation of glass- ancl nylon-wool IRNA fractions.
colIuimns. erctnt[ utt ceiis were (l(etermineIt
by incubatioin oflymphocytes, anti-O serum
ancl complement, using lymphocytes treat-
e(l with normal rabbit serum as control.
The percent complement-receptor lympho-
cyte.s (CRL) was calculated on the basis of
100 cells after inictubation of equal volumes
of 106 lymphocytes with 1% EAC (sensi-
tizel complement-coated sheep erythro-
cytes). Columns represent the mean of 6
values, bars the i-anige of the valu-es.
DISCUSSION
Poly(A)-tailed mRNA from IRNA was
found capable of transferring tumour-
specific cytotoxicity. Poly(A)-containing
mRNA sediments in sucrose to 9-18S and
makes up4-6%o ofthe total cellular IRNA.
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TABLE II. Cytotoxicity with adherent and non-adherentpoputlations ofnormal lymphocytes
RNA
Poly(A)+ IRNA
Poly(A)- IRNA
Total Cell IRNA
Poly(A)+ IRNA
Poly(A)- IRNA
Total Cell IRNA
RNA/4 x 106
lymphocytes
6-5 ,ug
93-5 jug
100 ,tg
6-5 tLg
9:3-5 ,tg
100 Hg
Effector cell
population
non-adherent
non-adherent
non-adhereiit
adherent
a(lherent
adherent
Target cells*
per well of
test cells±s.e.
26±2
51+3
34±2
56±4
45±2
61 ± 3
Target cells*
per wvell of %0
control cells+s.e. Cytotoxicityt
64± 2 59T
5:3±5 4
58±2 411
59t3 5
4112 -10
56:-3 -'9
* Mean of 18 replicate wells.
t Calculated as describe(d in the text, uising lymphocytes treatedl with normal RNA fractions as control.
I P'<0-001.
This agrees with work reported previously
in this laboratory that demonstrated frac-
tionation of IRNA on Sephadex G-200,
which produced an active component that
sedimented from 6 to 12S and made up
4*90o ofthe total IRNA (Dodd et al., 1973).
Several other investigators have shown,
using a variety of assay procedures, RNA
of this size capable of mediating immune
reactions. Fractionation of syngeneic
IRNA using preparative sucrose gradients
was shown to produce an active anti-
tumour fraction (12-16S) which mediated
cytotoxicity of murine tumour cells (Kern
et al., 1976). An RNA fraction which ac-
celerated skin allograft rejection in rabbits
sedimented in sucrose in the 8-18S region
(Mannick and Egdahl, 1964). Similarly, an
active RNA extracted from human lymph-
nodes capable of transferring PPD re-
activity to unsensitized cells appeared
localized in the 8-12S fraction (Thor and
Dray, 1973).
As demonstrated in Table I, RNA ex-
tracted from the lymphoid tissue of mice
immune to 4198V fibrosarcoma cells trans-
ferred specific cytotoxicity for the 4198V
target cell and not for the LM or the S91
cell lines. Likewise, RNA from both S91-
and LM-immune animal transferred a
specific response for each respective target
cell. Also, immune lymphocytes isolated
from the spleens of each group of mice did
not cross-react with target cells of a dif-
ferent origin. The transfer of specific cyto-
toxicity by syngeneic and xenogeneic
IRNA has been shown using other tumour
cell line systems (Kern et al., 1974, 1977).
The optimum dosage of poly(A)+IRNA
was determined (Fig. 2) to be 6-5 jig. This
is the amount of active fraction found in
the optimum dosage of total cellular RNA
(100 jug). Likewise, 93 5 og of poly(A)-
IRNA was obtained from 100 jug of total
cellular IRNA. A significant difference
(P<0 001) in percent cytotoxicity was
observed between treatment of 6 5 ,ug of
poly(A)+IRNA (50±2%, s.e., Trivers et
al., 1976) and 100 [kg oftotal cellularIRNA
(42±2%). This suggested that the differ-
ence in cytotoxicity was due to further
purification of the active RNA fraction,
either by removal of substances non-
specifically competing with poly(A)-
IRNA, or removal ofa specific suppressive
fraction of the RNA. Further work in this
area is currently under investigation inthis
laboratory.
The studies performed with adherent
and non-adherent cell populations suggest-
ed that not only was poly(A)+IRNA the
active component ofwhole-cell IRNA, but
also that the tumour-specific cytotoxicity
may be due to T-cell-mediated cytotoxi-
city. Since enrichment of the treated lym-
phocyte population for T cells did not in-
crease the level of cytotoxicity over that
seen with unseparated cell populations, it
appears that the maximum level of cyto-
toxicity for the system has been attained.
Cytotoxicity levels of 35-450 observed
with turnour-immune lymphocytes in the
same assay system substantiate this.
At this point, one can only speculate as
to what happens to the RNA once it is
taken into the cell. This messeng,er could
6162 C. J. GREENUP ET AL.
enter the cell, attach to the ribosomes, and
then begin to translate protein. This pro-
tein could change an appropriate cell-
surface receptor that commits the cell to
a cellular cytotoxic response. The protein
could be the light chain of an antibody
molecule or a regulatory protein. It is also
possible that poly(A)-tailed mRNA could
be a template for reverse transcriptase, in
which case a DNA copy of this message
would be integrated into the cell's genome.
At the present time, very little is known
about gene regulation in a normal cell,
much less what goes on in an immune cell
or in a cell given the information from an
immune cell.
The active fraction ofIRNA responsible
for transfer oftumour-specific cytotoxicity
has been isolated and further character-
ized. However, IRNA fractions which
mediate other types of immune reactions
(e.g. blocking antibody and antibody-
dependent cell-mediatedcytotoxicity) may
be present, and further studies on this
matter are in progress in this laboratory.
This work was supported, in part, by grants from
The National Cancer Institute, National Institutes
of Health #Ca-16867, The Ohio Chapter of the
American Cancer Society, and from the Graduate
School of The Ohio State University, Columbus,
Ohio.
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